Inhaled Reduced Glutathione — Competitive Intelligence Brief

Inhaled Reduced Glutathione (Inhaled Reduced Glutathione) competitive landscape: 3 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antioxidant / Mucolytic agent. Area: Respiratory / Pulmonary.

phase 3 Antioxidant / Mucolytic agent Glutathione (endogenous antioxidant system) Respiratory / Pulmonary Small molecule

Target snapshot

Inhaled Reduced Glutathione (Inhaled Reduced Glutathione) — Serafino A. Marsico. Inhaled reduced glutathione acts as an antioxidant and mucolytic agent that replenishes intracellular glutathione levels and reduces oxidative stress in the lungs.

Comparator set (3 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Inhaled Reduced Glutathione TARGET	Inhaled Reduced Glutathione	Serafino A. Marsico	phase 3	Antioxidant / Mucolytic agent	Glutathione (endogenous antioxidant system)
N-Acetyl Cysteine (NAC)	N-Acetyl Cysteine (NAC)	The Aurum Institute NPC	marketed	Antioxidant / Mucolytic agent	Glutathione synthesis pathway; reactive oxygen species (non-specific)
IV N-Acetyl Cystein	IV N-Acetyl Cystein	Imam Khomeini Hospital	phase 3	Antioxidant / Mucolytic agent	Glutathione synthesis pathway; free radicals and reactive oxygen species
IV N-acetylcysteine	IV N-acetylcysteine	Medical University of South Carolina	phase 3	Antioxidant / Mucolytic agent	Glutathione synthesis pathway; free radical scavenger

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antioxidant / Mucolytic agent class)

1. Imam Khomeini Hospital · 1 drug in this class
2. Medical University of South Carolina · 1 drug in this class
3. Serafino A. Marsico · 1 drug in this class
4. The Aurum Institute NPC · 1 drug in this class